| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 02/08/1996 | WO1996003048A1 Mixtures of genetically modified insect viruses with chemical and biological insecticides for enhanced insect control |
| 02/08/1996 | CA2196044A1 Insect viruses, sequences, insecticidal compositions and methods of use |
| 02/08/1996 | CA2195969A1 Mixtures of genetically modified insect viruses with chemical and biological insecticides for enhanced insect control |
| 02/08/1996 | CA2195539A1 Dna encoding ovine adenovirus (oav287) and its use as a viral vector |
| 02/08/1996 | CA2194465A1 Process for preparing viruses and viral vectors |
| 02/07/1996 | EP0695360A1 Defective recombinant adenoviruses for gene therapy of tumours |
| 02/01/1996 | WO1996002649A1 Modified plant viruses as vectors of heterologous peptides |
| 02/01/1996 | WO1996002634A1 Active calpain expressed by baculovirus |
| 02/01/1996 | WO1996002271A1 Electrically hydrolyzed salines as in vivo microbicides for the treatment of cardiomyopathy and multiple sclerosis |
| 02/01/1996 | DE4426429A1 Verfahren zum Einführen von DNA in höhere eukaryotische Zellen A method for introducing DNA into higher eukaryotic cells |
| 02/01/1996 | CA2195082A1 Electrically hydrolyzed salines as in vivo microbicides for the treatment of cardiomyopathy and multiple sclerosis |
| 02/01/1996 | CA2194763A1 Recombinant enzymatically active calpain expressed in a baculovirus system |
| 01/31/1996 | EP0694071A1 Adenovirus for the transfer of foreign dna into higher eucaryotic cells |
| 01/31/1996 | EP0694070A1 Recombinant alphavirus vectors |
| 01/28/1996 | CA2154640A1 Coated pesticidal agents, processes for their preparation and compositions containing them |
| 01/25/1996 | WO1996001902A1 Adenovirus comprising a gene coding for an no synthase |
| 01/25/1996 | WO1996001651A1 Attenuated human rotavirus vaccine |
| 01/25/1996 | WO1996001615A2 Hepatitis a virus deletion mutants and vaccine formulations containing the same |
| 01/25/1996 | CA2193263A1 Adenovirus comprising a gene coding for an no synthase |
| 01/24/1996 | EP0693551A1 gD-negative bovine herpesvirus mutant, capable of direct cell-to-cell transmission |
| 01/24/1996 | EP0451216B1 Humanized immunoglobulins and their production and use |
| 01/19/1996 | CA2154030A1 Gd-negative bovine herpesvirus mutant, capable of direct cell-to-cell transmission |
| 01/18/1996 | WO1996001324A2 Novel internal ribosome entry site, vector containing same and therapeutical use thereof |
| 01/18/1996 | WO1996001055A1 Insect control method with genetically engineered biopesticides |
| 01/18/1996 | CA2194155A1 Novel internal ribosome entry site, vector containing same and therapeutical use thereof |
| 01/17/1996 | EP0692532A1 Novel polypeptide, dna coding for said polypeptide, recombinant vector containing said dna, recombinant virus prepared using said vector, and use thereof |
| 01/17/1996 | EP0691828A1 Method of detecting compounds utilizing chemically modified lambdoid bacteriophage |
| 01/16/1996 | CA1337933C Hybrid rna virus |
| 01/15/1996 | CA2153760A1 Marek's disease virus vaccine |
| 01/11/1996 | WO1996000791A1 Recombinant infectious laryngotracheitis virus and vaccine |
| 01/11/1996 | WO1996000790A1 Adenovirus including a gene coding for a superoxide dismutase |
| 01/11/1996 | WO1996000587A1 Aav capsid vehicles for molecular transfer |
| 01/11/1996 | CA2193802A1 Aav capsid vehicles for molecular transfer |
| 01/11/1996 | CA2190883A1 Adenovirus including a gene coding for a superoxide dismutase |
| 01/10/1996 | EP0691404A2 Improved vaccines for the immunisation against TBE-Virusinfections and method for their preparation |
| 01/10/1996 | EP0691402A2 Modified satellite-RNA's and satellite-viruses as support for adapted ribozymes |
| 01/10/1996 | EP0690990A1 Parvovirus receptors and methods of use |
| 01/10/1996 | EP0690920A1 Biological control agents containing mollusc toxins |
| 01/10/1996 | EP0690915A1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
| 01/10/1996 | EP0690912A1 Recombinant avian adenovirus vector |
| 01/10/1996 | EP0487611B1 Herpes simplex virus type 1 mutant |
| 01/09/1996 | US5482713 Equine herpesvirus recombinant poxvirus vaccine |
| 01/04/1996 | WO1996000294A1 Improvements in or relating to delivery of nucleic acids |
| 01/04/1996 | WO1996000007A1 Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
| 01/04/1996 | WO1995030018A3 Recombinant poxviruses with foreign polynucleotides in essential regions |
| 01/04/1996 | WO1995025806A3 Packaging-deficient lentiviruses |
| 01/04/1996 | CA2193812A1 Improvements in or relating to delivery of nucleic acids |
| 01/03/1996 | EP0690129A1 Novel entities for cancer therapy |
| 01/03/1996 | EP0689604A1 Process for preparing cancer vaccines |
| 01/03/1996 | EP0689603A1 Defective mutant non-retroviral virus (e.g. hsv) as vaccine |
| 01/03/1996 | EP0689601A1 Production of high titer helper-free retroviruses by transient transfection |
| 01/03/1996 | EP0689593A1 Inhibition of selected tumor growth with recombinant viral sector |
| 01/03/1996 | EP0689447A1 Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 01/03/1996 | EP0317622B1 Prevention and treatment of retroviral disease |
| 01/03/1996 | EP0275300B1 Recombinant vaccine |
| 01/02/1996 | US5480968 Isolated polypeptide erbB-3, related to the epidermal growth factor receptor and antibody thereto |
| 01/02/1996 | US5480956 Feline interferon and process for production thereof |
| 01/02/1996 | US5480793 Nucleic acid coding for the human angiotensin converting enzyme (ACE), and its uses, especially for the in vitro diagnosis of arterial hypertension |
| 12/28/1995 | WO1995035380A1 Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections |
| 12/28/1995 | WO1995035369A1 METHODS AND COMPOSITIONS FOR cDNA SYNTHESIS |
| 12/28/1995 | WO1995016051A3 Methods and compositions for the suppression of neu mediated transformation |
| 12/28/1995 | CA2193487A1 Methods and compositions for cdna synthesis |
| 12/27/1995 | EP0688227A1 Production of human papillomavirus capsid protein and virus-like particles |
| 12/27/1995 | EP0578726B1 Virus inactivation method |
| 12/26/1995 | US5478746 cDNA encoding attenuated cell culture adapted hepatitis A virus genome |
| 12/26/1995 | US5478745 Recombinant viral vector system |
| 12/22/1995 | CA2131054A1 Macroporous hydrophobic cloth-based affinity-concentration device for microbiological and chemical analyses |
| 12/21/1995 | WO1995034686A1 Isolation and diagnosis of coronaviruses |
| 12/21/1995 | WO1995034684A1 Recombinant virus and related method of quantitating same |
| 12/21/1995 | WO1995034670A2 Recombinant aav genome encoding immunodeficiency virus protein |
| 12/21/1995 | WO1995034656A1 Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests |
| 12/21/1995 | WO1995032731A3 Immunogenic pharmaceuticals |
| 12/21/1995 | WO1995030761A3 Methods of in vivo gene delivery |
| 12/21/1995 | CA2576396A1 Adeno-associated virus materials and methods |
| 12/21/1995 | CA2192662A1 Method of detecting compounds utilizing genetically modified lambdoid bacteriophage |
| 12/20/1995 | EP0687728A2 Reovirus strain 2177 and vaccine containing same |
| 12/20/1995 | EP0687184A1 Recombinant adenoviruses and use thereof in gene therapy for treating eye diseases |
| 12/19/1995 | US5476781 Genetic engineering |
| 12/19/1995 | US5476778 Method of growing and attenuating a viral agent associated with mystery swine disease |
| 12/19/1995 | US5476658 Vaccine against hepatitis a comprising simian HAV isolate AGM-27 |
| 12/19/1995 | CA2011654C Recombinant poxvirus host range selection system |
| 12/14/1995 | WO1995033840A1 Recombinant viruses, preparation and use thereof in gene therapy |
| 12/14/1995 | WO1995033835A1 Nucleic acid immunization using a virus-based infection/transfection system |
| 12/14/1995 | CA2191362A1 Nucleic acid immunization using a virus-based infection/transfection system |
| 12/13/1995 | EP0686694A1 Use of azoles as virucidal agents in solutions of biologically active proteins |
| 12/13/1995 | CN1113390A Defective adenovirus vectors and use thereof in gene therapy |
| 12/12/1995 | US5474773 Human rotaviruses, vaccines and method |
| 12/11/1995 | CA2151446A1 Modified satellite rnas and satellite viruses as carriers of adapted ribozymes |
| 12/07/1995 | WO1995032733A1 Method of inducing an immune response with a live venezuelan equine encephalitis virus expressing a heterologous immunogen |
| 12/07/1995 | WO1995032731A2 Immunogenic pharmaceuticals |
| 12/06/1995 | EP0685236A1 Prevention and treatment of retroviral disease |
| 12/06/1995 | EP0610250B1 Porcine reproductive respiratory syndrome (prrs) vaccine and diagnostic |
| 11/30/1995 | WO1995032309A1 Treatment of influenza virus infection using antivirals that inhibit acylation/palmitylation of hemagglutinin |
| 11/30/1995 | WO1995032298A2 Safe vectors for gene therapy |
| 11/30/1995 | WO1995032291A2 Hepatitis g virus and molecular cloning thereof |
| 11/30/1995 | CA2190860A1 Hepatitis g virus and molecular cloning thereof |
| 11/30/1995 | CA2190581A1 Treatment of influenza virus infection using antivirals that inhibit acylation/palmitylation of hemagglutinin |
| 11/30/1995 | CA2190247A1 Safe vectors for gene therapy |
| 11/29/1995 | EP0683897A1 Method for detecting viral compounds using a glycoprotein. |
| 11/29/1995 | EP0683821A1 Rna packaging system |